Cheng, Peter T. W. team published research on Journal of Medicinal Chemistry in 2021 | 870-50-8

870-50-8, Di-tert-butyl azodicarboxylate, also known as Di-tert-butyl azodicarboxylate, is a useful research compound. Its molecular formula is C₁₀H₁₈N₂O₄ and its molecular weight is 230.26 g/mol. The purity is usually 95%.
Di-tert-butyl azodicarboxylate is a reagent used in the electrophilic amination of β-keto esters catalyzed by an axially chiral guanidine. Building block in an enantioselective synthesis of 3,6-dihyropyridazines employing organocatalysts such a L-proline or (S)-2-pyrrolidinyl tetrazole. Utilized in the asymmetric Friedel-Crafts amination via a chiral organocatalyst.
Di-tert-butyl azodicarboxylate is a reagent used in the preparation of acyl hydrazinedicarboxylates via photoorganocatalytic hydroacylation of dialkyl azodicarboxylates with aldehydes in presence of phenylglyoxylic acid as photocatalyst., Application In Synthesis of 870-50-8

Ester is a chemical compound derived from an oxoacid (organic or inorganic) in which at least one –OH hydroxyl group is replaced by an –O– alkyl (alkoxy) group, 870-50-8, formula is C10H18N2O4, Name is Di-tert-butyl diazene-1,2-dicarboxylate. as in the substitution reaction of a carboxylic acid and an alcohol. Application In Synthesis of 870-50-8.

Cheng, Peter T. W.;Kaltenbach, Robert F.;Zhang, Hao;Shi, Jun;Tao, Shiwei;Li, Jun;Kennedy, Lawrence J.;Walker, Steven J.;Shi, Yan;Wang, Ying;Dhanusu, Suresh;Reddigunta, Ramesh;Kumaravel, Selvakumar;Jusuf, Sutjano;Smith, Daniel;Krishnananthan, Subramaniam;Li, Jianqing;Wang, Tao;Heiry, Rebekah;Sum, Chi Shing;Kalinowski, Stephen S.;Hung, Chen-Pin;Chu, Ching-Hsuen;Azzara, Anthony V.;Ziegler, Milinda;Burns, Lisa;Zinker, Bradley A.;Boehm, Stephanie;Taylor, Joseph;Sapuppo, Julia;Mosure, Kathy;Everlof, Gerry;Guarino, Victor;Zhang, Lisa;Yang, Yanou;Ruan, Qian;Xu, Carrie;Apedo, Atsu;Traeger, Sarah C.;Cvijic, Mary Ellen;Lentz, Kimberley A.;Tirucherai, Giridhar;Sivaraman, Lakshmi;Robl, Jeffrey;Ellsworth, Bruce A.;Rosen, Glenn;Gordon, David A.;Soars, Matthew G.;Gill, Michael;Murphy, Brian J. research published 《 Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases》, the research content is summarized as follows. The oxycyclohexyl acid BMS-986278 (33) is a potent lysophosphatidic acid receptor 1 (LPA1) antagonist, with a human LPA1Kb of 6.9 nM. The structure-activity relationship (SAR) studies starting from the LPA1 antagonist clin. compound BMS-986020 (1), which culminated in the discovery of 33, are discussed. The detailed in vitro and in vivo preclin. pharmacol. profiles of 33, as well as its pharmacokinetics/metabolism profile, are described. On the basis of its in vivo efficacy in rodent chronic lung fibrosis models and excellent overall ADME (absorption, distribution, metabolism, excretion) properties in multiple preclin. species, 33 was advanced into clin. trials, including an ongoing Phase 2 clin. trial in patients with lung fibrosis (NCT04308681).

870-50-8, Di-tert-butyl azodicarboxylate, also known as Di-tert-butyl azodicarboxylate, is a useful research compound. Its molecular formula is C₁₀H₁₈N₂O₄ and its molecular weight is 230.26 g/mol. The purity is usually 95%.
Di-tert-butyl azodicarboxylate is a reagent used in the electrophilic amination of β-keto esters catalyzed by an axially chiral guanidine. Building block in an enantioselective synthesis of 3,6-dihyropyridazines employing organocatalysts such a L-proline or (S)-2-pyrrolidinyl tetrazole. Utilized in the asymmetric Friedel-Crafts amination via a chiral organocatalyst.
Di-tert-butyl azodicarboxylate is a reagent used in the preparation of acyl hydrazinedicarboxylates via photoorganocatalytic hydroacylation of dialkyl azodicarboxylates with aldehydes in presence of phenylglyoxylic acid as photocatalyst., Application In Synthesis of 870-50-8

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics